Searched for
IND SWIFT
Ahead of Market: 10 things that will decide stock market action on MondayIndian equities ended higher, led by consumer and metal stocks, while IT lagged due to weak earnings. Nifty and Sensex posted gains with po...19 Apr, 2026, 12.53 PM IST- NCLAT stays bankruptcy proceedings against Ind-SwiftInd-Swift was admitted for corporate insolvency on September 12 on a petition by trader creditor Allcare Containers claiming overdues of ₹3...18 Sep, 2023, 12.41 AM IST
- lndiaRF to acquire API, CRAMS business of Ind-Swift LabsIndiaRF will acquire the active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) business of Ind-S...06 Sep, 2023, 03.55 PM IST
- Ind-Swift in talks with PE companies to sell stakeChandigarh-based Ind-Swift had called off the business transfer agreement with PI Industries to sell a unit of the company. As per the new ...18 Nov, 2021, 06.37 AM IST
- PI Industries to acquire API biz from Ind-Swift LabsInd-Swift Laboratories has agreed to sell its Active Pharmaceuticals Ingredients (API) business to PI Industries on a slump sale basis, bot...31 Jul, 2021, 12.33 PM IST
- Ind Swift Laboratories Q3 loss narrows to Rs 12.37 croreThe company had a net loss of Rs 13.55 crore in the same period previous fiscal, Ind Swift Laboratories informed the BSE.09 Feb, 2015, 01.25 PM IST
- Ind-Swift in stake sale talks with US companies to raise Rs 200 croreInd-Swift Laboratories is in talks with two leading US based firms for strategic stake sale to mop up Rs 200 crore, said sources.30 Jul, 2014, 12.22 PM IST
- Ind-Swift Labs aims to touch Rs 1,500 crore turnover by 2015Drug firm Ind-Swift Laboratories has set a target of achieving revenues of Rs 1,500 crore by 2015 with overseas markets like Japan.09 Dec, 2012, 11.49 AM IST
- Ind Swift Laboratories up 13% on Piramal stake buy reportsInd Swift Lab surged over 13% on reports that the Piramal Healthcare is in talks to acquire Ind Swift’s contract research and manufacturing...04 Sep, 2012, 10.46 AM IST
- Buy Ind-Swift Laboratories with a target of 57: Sandeep WagleInd-Swift Laboratories Ltd is a ‘BUY’ call with a target of Rs 57 and a stop loss of Rs 48.04 Sep, 2012, 09.38 AM IST
- Buy Ind-Swift Laboratories with a target of 51: Sandeep WagleInd-Swift Laboratories Ltd is a ‘BUY’ call with a target of Rs 51 and a stop loss of Rs 44.50.27 Aug, 2012, 09.25 AM IST
- Ind-Swift, Wockhardt launch Atorvastatin tablets in UKInd-Swift Laboratories today said it has launched generic formulations of Atorvastatin in the UK in collaboration with Wockhardt.16 May, 2012, 10.36 PM IST
- Ind Swift Lab get USFDA nod for 5 products; stock gainsShares of Ind Swift Laboratories surged higher as the company got USFDA approval for 5 active pharmaceutical ingredients at its Derabassi p...12 Apr, 2012, 10.50 AM IST
- Ind Swift get USFDA nod for five active pharmaceutical ingredientsInd Swift Laboratories today said it has received US health regulator's approval to sell five active pharmaceutical ingredients.10 Apr, 2012, 05.55 PM IST
- Ind Swift Lab gets Australia's nod for its Dera Bassi plantDrug firm Ind Swift said it has received approval from the Australian health regulator to make seven active pharmaceutical ingredients.23 Sep, 2011, 08.27 PM IST
- Ind Swift Lab Q3 net up 83% to Rs 24.61 crInd Swift Laboratories on Monday said its net profit rose by 82.97 per cent to Rs 24.61 crore for the third quarter ended December 31, 2010...31 Jan, 2011, 01.49 PM IST
- Ind-Swift Labs in strong uptrend: Deepak MohoniSecond-rung pharmas are not only creating high volumes right now but are also in pretty strong uptrends and that is where this Ind-Swift La...01 Sep, 2010, 11.41 AM IST
Load More
